5 Key Sessions at the American Society of Nephrology Kidney Week

The American Society of Nephrology (ASN) Kidney Week is an annual event that brings together more than 10,000 professionals working in the kidney health care space from around the world. This year, experts in the field will meet in Orlando, Florida to exchange knowledge, get up to date on the most recent advances in the scientific and medical communities, and hear sessions from across hundreds of focuses.

Pharmacy Times coverage of ASN Kidney Week sessions will include:

• On Thursday, November 3, Pharmacy Times sits in on a session titled “The Patient Journey with Diabetic Kidney Disease,” which provides a look into the patient perspective. Speakers will specifically look at holistic care, where they discuss how patients can be aware and detect diabetic kidney disease—they will also highlight interventions that can save lives.
• Friday, November 4, Pharmacy Times will cover a session called, “Update on the Management of Recurrent Hyperkalemia Associated with RAAS Inhibitors in Patients with CKD and ESRD.” In this session, speakers will discuss potassium metabolism physiology and the occurrence of recurrent hyperkalemia for patients while on treatment.
• Also on Friday, Pharmacy Times will cover the session “Developing Personalized Medicine for Peritoneal Dialysis Patients,” during which the presenters aim to discuss the goals of individualized dialysis therapy, approaches to characterizing patient risk, the relationship between genes and the environment on personal outcomes, and cytoprotective approaches in peritoneal dialysis.
• On Saturday, Pharmacy Times will be covering the clinical science session “Role of Basolateral Potassium Channel in Potassium Homeostasis and Diseases.” In this session, presenters will discuss basolateral potassium channels in nephrons, what happens when there are mutations, and their role in salt wasting disorder and kidney sodium handling.
• Finally, Pharmacy Times plans to cover “Advancing Home Dialysis with Technologies and Education.” Statistics suggest that 87% of patients with end-stage kidney disease (ESKD) receive in-center hemodialysis, but this session will provide insight from speakers who find that education about kidney diseases and home dialysis could improve patient awareness of alternative options.

Stay tuned on PharmacyTimes.com and follow Pharmacy Times on social media for exclusive, live coverage and the latest updates from ASN Kidney Week.